优化了CRISPR-Cas9系统,用于在癌细胞中高效地设计ecDNA
Yohei Sugimoto1, Takeru Kachi1, Yu Watanabe1,2
1Division of Molecular Oncology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Nucleic acids research
|January 14, 2026
概括
一个新的保护CRISPR-Cas9系统有效地设计了染色体外DNA (ecDNA),克服了癌症研究的局限性. 这种优化的工具允许精确的ecDNA编辑,用于研究瘤异质性和耐药性.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
背景情况:
- 外染色体DNA (ecDNA) 放大对于瘤基因放大,瘤异质性和癌症中耐药性至关重要.
- 了解ecDNA生物学受限于缺乏工程和监测其动态的工具.
- 对于每个细胞的高副本数量存在的ecDNA,基因组工程策略尚未建立.
研究的目的:
- 使用CRISPR-Cas9系统系统地验证ecDNA编辑.
- 开发和优化CRISPR-Cas9系统,以实现高效且无破坏性的ecDNA工程.
- 为研究ecDNA生物学提供一个强大的工具.
主要方法:
- 标准CRISPR-Cas9和优化CRISPR-Cas9与保护单导向RNA (sgRNAs) 的系统验证.
- 优化涉及修改sgRNAs与细胞因子扩展以减少Cas9活动.
- 计算模拟以了解DNA裂变事件对细胞结果的影响.
主要成果:
- 传统的CRISPR-Cas9引起了细胞毒性,减少了ecDNA拷贝数量和微核形成,具有低的敲进效率.
- 保护sgRNA策略以剂量依赖的方式降低了细胞毒性和ecDNA损失.
- 通过使用优化的系统,实现了每个细胞的多个ecDNA副本的高效敲入.
结论:
- 使用保护性sgRNA优化Cas9活动,可实现高效且无破坏性的ecDNA工程.
- 这种优化的系统克服了以前编辑高副本ecDNA的限制.
- 为推进癌症中的ecDNA生物学研究提供了一个强大的新工具.
相关概念视频
01:28CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
01:59CRISPR
57.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K
02:31Homologous Recombination
62.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.6K
02:53CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
02:53Conservative Site-specific Recombination and Phase Variation
6.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.7K